Johnson & Johnson Statistics
Total Valuation
JNJ has a market cap or net worth of $365.75 billion. The enterprise value is $379.22 billion.
| Market Cap | 365.75B |
| Enterprise Value | 379.22B |
Important Dates
The next confirmed earnings date is Wednesday, July 16, 2025, before market open.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | May 27, 2025 |
Share Statistics
JNJ has 2.41 billion shares outstanding. The number of shares has decreased by -3.53% in one year.
| Current Share Class | 2.41B |
| Shares Outstanding | 2.41B |
| Shares Change (YoY) | -3.53% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 74.03% |
| Float | 2.40B |
Valuation Ratios
The trailing PE ratio is 16.92 and the forward PE ratio is 14.42. JNJ's PEG ratio is 1.75.
| PE Ratio | 16.92 |
| Forward PE | 14.42 |
| PS Ratio | 4.10 |
| Forward PS | 3.92 |
| PB Ratio | 4.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 17.95 |
| P/OCF Ratio | 14.76 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.63, with an EV/FCF ratio of 18.62.
| EV / Earnings | 17.39 |
| EV / Sales | 4.25 |
| EV / EBITDA | 12.63 |
| EV / EBIT | 16.68 |
| EV / FCF | 18.62 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.26 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 1.73 |
| Debt / FCF | 2.57 |
| Interest Coverage | 28.27 |
Financial Efficiency
Return on equity (ROE) is 29.45% and return on invested capital (ROIC) is 12.14%.
| Return on Equity (ROE) | 29.45% |
| Return on Assets (ROA) | 7.77% |
| Return on Invested Capital (ROIC) | 12.14% |
| Return on Capital Employed (ROCE) | 16.62% |
| Revenue Per Employee | $646,857 |
| Profits Per Employee | $157,929 |
| Employee Count | 138,100 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.31 |
Taxes
In the past 12 months, JNJ has paid $4.79 billion in taxes.
| Income Tax | 4.79B |
| Effective Tax Rate | 18.02% |
Stock Price Statistics
The stock price has increased by +3.28% in the last 52 weeks. The beta is 0.41, so JNJ's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +3.28% |
| 50-Day Moving Average | 153.94 |
| 200-Day Moving Average | 155.80 |
| Relative Strength Index (RSI) | 45.22 |
| Average Volume (20 Days) | 8,112,316 |
Short Selling Information
The latest short interest is 19.22 million, so 0.80% of the outstanding shares have been sold short.
| Short Interest | 19.22M |
| Short Previous Month | 19.68M |
| Short % of Shares Out | 0.80% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
In the last 12 months, JNJ had revenue of $89.33 billion and earned $21.81 billion in profits. Earnings per share was $8.98.
| Revenue | 89.33B |
| Gross Profit | 61.55B |
| Operating Income | 22.73B |
| Pretax Income | n/a |
| Net Income | 21.81B |
| EBITDA | 30.03B |
| EBIT | 22.73B |
| Earnings Per Share (EPS) | $8.98 |
Balance Sheet
The company has $38.78 billion in cash and $52.25 billion in debt, giving a net cash position of -$13.47 billion or -$5.60 per share.
| Cash & Cash Equivalents | 38.78B |
| Total Debt | 52.25B |
| Net Cash | -13.47B |
| Net Cash Per Share | -$5.60 |
| Equity (Book Value) | 78.11B |
| Book Value Per Share | 32.47 |
| Working Capital | 14.65B |
Cash Flow
In the last 12 months, operating cash flow was $24.78 billion and capital expenditures -$4.41 billion, giving a free cash flow of $20.37 billion.
| Operating Cash Flow | 24.78B |
| Capital Expenditures | -4.41B |
| Free Cash Flow | 20.37B |
| FCF Per Share | $8.47 |
Margins
Gross margin is 68.90%, with operating and profit margins of 25.44% and 24.41%.
| Gross Margin | 68.90% |
| Operating Margin | 25.44% |
| Pretax Margin | 29.78% |
| Profit Margin | 24.41% |
| EBITDA Margin | 33.61% |
| EBIT Margin | 25.44% |
| FCF Margin | 22.80% |
Dividends & Yields
This stock pays an annual dividend of $5.20, which amounts to a dividend yield of 3.42%.
| Dividend Per Share | $5.20 |
| Dividend Yield | 3.42% |
| Dividend Growth (YoY) | 4.37% |
| Years of Dividend Growth | 63 |
| Payout Ratio | 55.87% |
| Buyback Yield | 3.53% |
| Shareholder Yield | 6.95% |
| Earnings Yield | 5.96% |
| FCF Yield | 5.57% |
Analyst Forecast
The average price target for JNJ is $169.33, which is 11.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $169.33 |
| Price Target Difference | 11.39% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 4.07% |
| EPS Growth Forecast (5Y) | 18.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 13, 2001. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 13, 2001 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
JNJ has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 6 |